* CE marked in 2015.
1. All-comer as per definition of Inclusion criteria of LEADERS FREE: Age >75, Oral anticoagulants, Cancer, Surgery soon, poor DAPT compliance anticipated post PCI, Renal failure, Anemia, Thrombocytopenia, Previous stroke, Liver failure, Admission for bleeding, NSAID / Steroids, Prior intra cerebral bleed.
2. Biosensors International data on file.
3. Garot P. et al. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents. JACC VOL.6 9, No.2 , 2017

BioFreedom and BioFreedom Ultra are a trademark or registered trademark of Biosensors International Group, Ltd. BioFreedom™ and BioFreedom™ Ultra are CE Mark approved. CAUTION: The law restricts these devices to sale by or on the order of a physician and these products are intended for the use by or under the direction of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Not available in the United States and any other country where applicable health authority product registration has not been obtained. Information contained herein only for presentation outside the US and France. © 2020 Biosensors International Group, Ltd. All rights reserved. 12265-000-EN – Rev.01.